Nektar Therapeutics

NASDAQ: NKTR
Share price (9/29/25): $58.92
Market cap (9/29/25): $1.121 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-K 65 pages Asset Purchase Agreement Dated as of October 20, 2008 by and Between Nektar Therapeutics (The “Company”), Aerogen, Inc. (The “Transferring Subsidiary”), Novartis Pharmaceuticals Corporation (The “Buyer”) and Novartis Pharma AG

from 8-K 62 pages Agreement and Plan of Merger Dated as of August 12, 2005 Among Nektar Therapeutics Oski Acquisition Corporation and Aerogen, Inc

from 8-K ~1 page Amendment to Agreement and Plan of Merger and Reorganization

from 8-K ~50 pages Agreement and Plan of Merger and Reorganization Among: Inhale Therapeutic Systems, Inc., a Delaware Corporation; Square Acquisition Corp., an Alabama Corporation; Shearwater Corporation, an Alabama Corporation; Certain Shareholders of Shearwater Corporation and J. Milton Harris, as Shareholders' Agent Dated as of May 22, 2001 Exhibits

from 8-K >50 pages Plan of reorganization, merger, acquisition or similar

from 10-Q ~5 pages Plan of reorganization, merger, acquisition or similar